Eli Lilly’s website points out that it has chosen to focus on five therapeutic areas—diabetes, cancer, immunology, pain and neurodegeneration. The site notes, “We see ample opportunity to execute better, move faster and deliver new medicines that improve the lives of millions of people.”
Delivering those often temperature-sensitive medicines to patients worldwide, of course, requires logistics expertise. On Jan. 16, from 1:30-2 p.m. Eastern time, two Eli Lilly and Company experts will present an ISTA (Intl. Safe Transportation Assn.) Developing Climatic OQ Thermal Challenges Profiles Webinar.
The presenters are Bryan Cardis, Consultant Cold Chain and Packaging Engineer, and Jeffrey Chida, Consultant Engineer.
ISTA describes the webinar conference, saying, “There are times when products will be distributed in areas, geographic zones that might not have actual collected shipping lane ambient temperature data in order to generate thermal OQ profiles in order to qualify temperature-controlled shipping containers. Lilly has developed a process to utilize climatic data to support these undefined regions in order to develop a thermal OQ profile in the absence of actual lane data to support commercialization of the product supply chain.”
